Advertisement
U.S. markets open in 7 minutes
  • S&P Futures

    5,310.00
    +1.75 (+0.03%)
     
  • Dow Futures

    40,188.00
    +44.00 (+0.11%)
     
  • Nasdaq Futures

    18,504.75
    +1.00 (+0.01%)
     
  • Russell 2000 Futures

    2,142.40
    +4.00 (+0.19%)
     
  • Crude Oil

    82.45
    +1.10 (+1.35%)
     
  • Gold

    2,233.00
    +20.30 (+0.92%)
     
  • Silver

    24.78
    +0.03 (+0.13%)
     
  • EUR/USD

    1.0810
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2637
    -0.0001 (-0.01%)
     
  • USD/JPY

    151.3280
    +0.0820 (+0.05%)
     
  • Bitcoin USD

    70,618.07
    -672.98 (-0.94%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,953.94
    +21.96 (+0.28%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Inspire Medical Systems, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference

MINNEAPOLIS, April 28, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the BofA Securities 2021 Virtual Health Care Conference on May 12, 2021.

Inspire is scheduled to present at 12:30 p.m. Eastern Time. The presentation will be accessible via a live webcast at https://www.veracast.com/webcasts/bofa/hc2021/id6821zv.cfm.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989


Advertisement